Tjalf Ziemssen, MD, PhD is Director of the Center of Clinical Neuroscience with its Multiple Sclerosis Centre (MSC), neuroimmunological lab (NIL) and autonomic lab (ANF) at the Carl Gustav Carus University Hospital, in Dresden, Germany.
He obtained his medical degree from the University of Bochum, Germany in 1998 and completed his doctoral thesis in 1999 at the Institute of Clinical Chemistry, University of Bochum, Germany. He then underwent training as a Fellow of Neurology at the Carl Gustav Carus University Hospital in Dresden and as a Research Fellow at the Max-Planck Institute of Neurobiology in Martinsried, Germany. He became Director of the MSC Dresden in 2007 and, in 2011 he became Professor of Clinical Neurosciences and Head of the Centre for Clinical Neuroscience at the Carl Gustav Carus University Hospital. He is also Head of the Autonomic and Neuroendocrine Function laboratories (ANF) and the Neuroimmunological Laboratories (NIL).
Professor Ziemssen’s research interests include the dual role of inflammation in the brain and the mechanisms of autoimmunity and tolerance. In addition, he is interested in the autonomic nervous system in health and disease. He is involved in clinical studies and has published over 130 papers. He has received several awards including awards from the European Charcot foundation and the German Ophthalmological Society.
He is an active member of several neurological societies, including the German Neurological Society, the European Neurological Society, the American Academy of Neurology and the European Federation of Autonomic Societies.
Fees for consulting or research support from Almirall, Bayer, Biogen, Genzyme, GlaxoSmithKline, MSD, Merck Serono, Novartis, Sanofi, Synthon, and Teva